Success Metrics

Clinical Success Rate
83.0%

Based on 73 completed trials

Completion Rate
83%(73/88)
Active Trials
27(20%)
Results Posted
62%(45 trials)
Terminated
15(11%)

Phase Distribution

Ph not_applicable
69
51%
Ph phase_1
8
6%
Ph phase_3
33
24%
Ph phase_4
3
2%
Ph phase_2
22
16%

Phase Distribution

8

Early Stage

22

Mid Stage

36

Late Stage

Phase Distribution135 total trials
Phase 1Safety & dosage
8(5.9%)
Phase 2Efficacy & side effects
22(16.3%)
Phase 3Large-scale testing
33(24.4%)
Phase 4Post-market surveillance
3(2.2%)
N/ANon-phased studies
69(51.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.2%

73 of 91 finished

Non-Completion Rate

19.8%

18 ended early

Currently Active

27

trials recruiting

Total Trials

136

all time

Status Distribution
Active(31)
Completed(73)
Terminated(18)
Other(14)

Detailed Status

Completed73
Recruiting18
Terminated15
unknown13
Active, not recruiting9
Not yet recruiting4

Development Timeline

Analytics

Development Status

Total Trials
136
Active
27
Success Rate
83.0%
Most Advanced
Phase 4

Trials by Phase

Phase 18 (5.9%)
Phase 222 (16.3%)
Phase 333 (24.4%)
Phase 43 (2.2%)
N/A69 (51.1%)

Trials by Status

active_not_recruiting97%
recruiting1813%
completed7354%
not_yet_recruiting43%
suspended11%
unknown1310%
terminated1511%
withdrawn32%

Recent Activity

Clinical Trials (136)

Showing 20 of 136 trialsScroll for more
NCT07165041Not Applicable

Efficacy of Serratus Posterior Superior Intercostal Plane Block in Cardiac Device Implantation

Completed
NCT07083765Phase 3

Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)

Suspended
NCT02649426Not Applicable

A Study of the ReCor Medical Paradise System in Clinical Hypertension

Active Not Recruiting
NCT07504640Not Applicable

The Effect of Spinal Manipulation on Heart Rate Variability in Children With Cerebral Palsy.

Not Yet Recruiting
NCT05685134Not Applicable

Epicardial Radiofrequency Catheter Ablation in Patients With Brugada Syndrome

Active Not Recruiting
NCT06635148Phase 2

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Recruiting
NCT07495852Phase 3

Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Recruiting
NCT06430385Phase 1

ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)

Recruiting
NCT06176352Phase 3

A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia

Active Not Recruiting
NCT05686317Not Applicable

ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System

Active Not Recruiting
NCT05811351Phase 2

A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Completed
NCT06745453Not Applicable

Erector Spinae Plane Block for Acute Back Pain in the Emergency Department

Recruiting
NCT07444450Phase 3

A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec

Not Yet Recruiting
NCT07075718Phase 2

Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Recruiting
NCT04967170Phase 1

A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus

Active Not Recruiting
NCT06178055Phase 2

A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arteritic Central Retinal Artery Occlusion (CRAO)

Completed
NCT04432831Phase 3

A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema

Completed
NCT07073040Not Applicable

Efficacy and Safety of Cold Atmospheric Plasma Combined With Endovascular Intervention in Patients With Diabetic Foot Ulcers and Lower Extremity Arterial Occlusion

Recruiting
NCT06092476Not Applicable

Trial to Evaluate Efficacy+Safety of Revita DMR Treatment Paradigm 1 and Retreatment in Type 2 Diabetes Patients

Recruiting
NCT05984238Not Applicable

A Trial to Evaluate Safety, Feasibility and Efficacy of the ReCET Procedure (EMINENT-2)

Active Not Recruiting

Drug Details

Intervention Type
PROCEDURE
Total Trials
136